159 related articles for article (PubMed ID: 37958846)
1. Establishment and Comprehensive Molecular Characterization of an Immortalized Glioblastoma Cell Line from a Brazilian Patient.
da Silva FF; Lupinacci FCS; Elias BDS; Beserra AO; Sanematsu P; Roffe M; Kulikowski LD; Costa FD; Santos TG; Hajj GNM
Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958846
[TBL] [Abstract][Full Text] [Related]
2. Detection of primary cilia in human glioblastoma.
Sarkisian MR; Siebzehnrubl D; Hoang-Minh L; Deleyrolle L; Silver DJ; Siebzehnrubl FA; Guadiana SM; Srivinasan G; Semple-Rowland S; Harrison JK; Steindler DA; Reynolds BA
J Neurooncol; 2014 Mar; 117(1):15-24. PubMed ID: 24510433
[TBL] [Abstract][Full Text] [Related]
3. Targeting βIII-tubulin in glioblastoma multiforme: from cell biology and histopathology to cancer therapeutics.
Katsetos CD; Draber P; Kavallaris M
Anticancer Agents Med Chem; 2011 Oct; 11(8):719-28. PubMed ID: 21707498
[TBL] [Abstract][Full Text] [Related]
4. Neuronal markers are expressed in human gliomas and NSE knockdown sensitizes glioblastoma cells to radiotherapy and temozolomide.
Yan T; Skaftnesmo KO; Leiss L; Sleire L; Wang J; Li X; Enger PØ
BMC Cancer; 2011 Dec; 11():524. PubMed ID: 22185371
[TBL] [Abstract][Full Text] [Related]
5. Hypoxia-inducible factor-2α (HIF-2α), but not HIF-1α, is essential for hypoxic induction of class III β-tubulin expression in human glioblastoma cells.
Bordji K; Grandval A; Cuhna-Alves L; Lechapt-Zalcman E; Bernaudin M
FEBS J; 2014 Dec; 281(23):5220-36. PubMed ID: 25244496
[TBL] [Abstract][Full Text] [Related]
6. A novel biphenyl diester derivative, AB38b, inhibits glioblastoma cell growth via the ROS-AKT/mTOR pathway.
Meng Q; Zhou J; You F; Wu Y; Yang L; Wang Y; Zhang X; Gao S; Yu R; Yin X
Biochem Pharmacol; 2021 Dec; 194():114795. PubMed ID: 34687671
[TBL] [Abstract][Full Text] [Related]
7. Integrative analysis of cell adhesion molecules in glioblastoma identified prostaglandin F2 receptor inhibitor (PTGFRN) as an essential gene.
Mala U; Baral TK; Somasundaram K
BMC Cancer; 2022 Jun; 22(1):642. PubMed ID: 35690717
[TBL] [Abstract][Full Text] [Related]
8. Wild‑type IDH1 affects cell migration by modulating the PI3K/AKT/mTOR pathway in primary glioblastoma cells.
Shen X; Wu S; Zhang J; Li M; Xu F; Wang A; Lei Y; Zhu G
Mol Med Rep; 2020 Sep; 22(3):1949-1957. PubMed ID: 32705169
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol targeting of AKT and p53 in glioblastoma and glioblastoma stem-like cells to suppress growth and infiltration.
Clark PA; Bhattacharya S; Elmayan A; Darjatmoko SR; Thuro BA; Yan MB; van Ginkel PR; Polans AS; Kuo JS
J Neurosurg; 2017 May; 126(5):1448-1460. PubMed ID: 27419830
[TBL] [Abstract][Full Text] [Related]
10. Tubulin targets in the pathobiology and therapy of glioblastoma multiforme. I. Class III beta-tubulin.
Katsetos CD; Dráberová E; Legido A; Dumontet C; Dráber P
J Cell Physiol; 2009 Dec; 221(3):505-13. PubMed ID: 19650075
[TBL] [Abstract][Full Text] [Related]
11. PTP4A3 is a target for inhibition of cell proliferatin, migration and invasion through Akt/mTOR signaling pathway in glioblastoma under the regulation of miR-137.
Wang L; Liu J; Zhong Z; Gong X; Liu W; Shi L; Li X
Brain Res; 2016 Sep; 1646():441-450. PubMed ID: 27328425
[TBL] [Abstract][Full Text] [Related]
12. Isolation and partial characterization of a new human glioblastoma cell line.
Brehar FM; Bleotu C; Stefan LM; Buzgariu W; Chivu M; Utoiu E; Matei L; Ciurea AV; Tascu A
Chirurgia (Bucur); 2009; 104(4):453-61. PubMed ID: 19886054
[TBL] [Abstract][Full Text] [Related]
13. Establishment and characteristics of GWH04, a new primary human glioblastoma cell line.
Cheng F; Wan X; Wang B; Li Y; Peng P; Xu S; Han C; Mao F; Guo D
Int J Oncol; 2022 Nov; 61(5):. PubMed ID: 36169178
[TBL] [Abstract][Full Text] [Related]
14. EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence.
Li L; Huang Y; Gao Y; Shi T; Xu Y; Li H; Hyytiäinen M; Keski-Oja J; Jiang Q; Hu Y; Du Z
BMC Cancer; 2018 Dec; 18(1):1215. PubMed ID: 30514230
[TBL] [Abstract][Full Text] [Related]
15. Progesterone at high doses reduces the growth of U87 and A172 glioblastoma cells: Proteomic changes regarding metabolism and immunity.
Altinoz MA; Ucal Y; Yilmaz MC; Kiris İ; Ozisik O; Sezerman U; Ozpinar A; Elmaci İ
Cancer Med; 2020 Aug; 9(16):5767-5780. PubMed ID: 32590878
[TBL] [Abstract][Full Text] [Related]
16. Anti-SEMA3A Antibody: A Novel Therapeutic Agent to Suppress Glioblastoma Tumor Growth.
Lee J; Shin YJ; Lee K; Cho HJ; Sa JK; Lee SY; Kim SH; Lee J; Yoon Y; Nam DH
Cancer Res Treat; 2018 Jul; 50(3):1009-1022. PubMed ID: 29129044
[TBL] [Abstract][Full Text] [Related]
17. Notch- and vitamin D signaling in 1,25(OH)2D3-resistant glioblastoma multiforme (GBM) cell lines.
Reichrath S; Müller CS; Gleissner B; Pfreundschuh M; Vogt T; Reichrath J
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):420-4. PubMed ID: 20206691
[TBL] [Abstract][Full Text] [Related]
18. Methylation regulates HEY1 expression in glioblastoma.
Tsung AJ; Guda MR; Asuthkar S; Labak CM; Purvis IJ; Lu Y; Jain N; Bach SE; Prasad DVR; Velpula KK
Oncotarget; 2017 Jul; 8(27):44398-44409. PubMed ID: 28574840
[TBL] [Abstract][Full Text] [Related]
19. Loss of programmed cell death 10 activates tumor cells and leads to temozolomide-resistance in glioblastoma.
Nickel AC; Wan XY; Saban DV; Weng YL; Zhang S; Keyvani K; Sure U; Zhu Y
J Neurooncol; 2019 Jan; 141(1):31-41. PubMed ID: 30392087
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome.
Bai Y; Zhang QG; Wang XH
Eur J Med Res; 2014 Dec; 19(1):66. PubMed ID: 25498217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
